Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2017-10-20 (8 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: GRAMAT (46500), Lot
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE EDITH LALO : revenue, balance sheet and financial ratios
PHARMACIE EDITH LALO is a French company
founded 8 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in GRAMAT (46500),
this company of category PME
shows in 2025 a net income positive of 47 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE EDITH LALO (SIREN 832787105)
Indicator
2025
2024
2023
2022
2021
2020
2019
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
46 944 €
44 527 €
55 380 €
71 192 €
59 716 €
54 952 €
55 123 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE EDITH LALO generates positive net income of 47 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2019-2025: 55 k€ -> 47 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
46 944 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 17%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 72%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
17.307%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
71.6%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
2021
2022
2023
2024
2025
Debt ratio
206.756
130.011
76.273
42.001
42.202
27.824
17.307
Financial autonomy
21.112
29.582
40.359
47.522
54.976
64.706
71.6
Repayment capacity
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
17.312025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good-9 pts over 3 years
In 2025, the debt ratio of PHARMACIE EDITH LALO (17.31) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
71.6%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good+16 pts over 3 years
In 2025, the financial autonomy of PHARMACIE EDITH LALO (71.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 289.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
150.119
181.841
206.524
197.834
220.973
252.225
289.659
Interest coverage
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
289.662025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Excellent+15 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE EDITH LALO (289.66) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Positioning of PHARMACIE EDITH LALO in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE EDITH LALO is estimated at
745 711 €
(range 506 043€ - 1 170 123€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
506k€745k€1170k€
745 711 €Range: 506 043€ - 1 170 123€
NAF 5 année 2025
Valuation method used
Net Income Multiple
46 944 €
×
15.9x
=745 711 €
Range: 506 043€ - 1 170 123€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE EDITH LALO with other companies in the same sector:
Frequently asked questions about PHARMACIE EDITH LALO
What is the revenue of PHARMACIE EDITH LALO ?
The revenue of PHARMACIE EDITH LALO is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE EDITH LALO profitable?
Yes, PHARMACIE EDITH LALO generated a net profit of 47 k€ in 2025.
Where is the headquarters of PHARMACIE EDITH LALO ?
The headquarters of PHARMACIE EDITH LALO is located in GRAMAT (46500), in the department Lot.
Where to find the tax return of PHARMACIE EDITH LALO ?
The tax return of PHARMACIE EDITH LALO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE EDITH LALO operate?
PHARMACIE EDITH LALO operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart